FdaApplication
ANDA 210882
Identifiers
- fda_app_no: ANDA210882
Properties
| Property | Value |
|---|---|
| applicant_name | SOMERSET THERAPEUTICS LLC |
| application_type | ANDA |
| approval_date | 2018-08-17 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SODIUM NITROPRUSSIDE | SODIUM NITROPRUSSIDE | 25MG/ML | INJECTABLE;INJECTION |
1 product